Description

Artoxan (Tenoxicam) Lyophilisate for Injections 20 mg. Vial № 3+ Solvent Ampoules

Ingredients:

Each vial contains 20 mg of tenoxicam. The solvent ampoules are provided to facilitate the reconstitution of the lyophilisate for injection.

Dosage:

The usual dose is 20 mg once daily. Dosage may vary based on the condition being treated. It is important to follow the instructions provided by your healthcare provider.

Indications:

Artoxan is indicated for the relief of pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis. It helps reduce pain, swelling, and joint stiffness.

Contraindications:

Do not use Artoxan if you have a history of allergic reactions to tenoxicam or other NSAIDs. It is contraindicated in patients with active peptic ulcers or gastrointestinal bleeding.

Directions:

Artoxan is for intramuscular use only. The lyophilisate should be reconstituted with the provided solvent before injection. Follow proper aseptic techniques during reconstitution and administration.

Scientific Evidence:

Tenoxicam, the active ingredient in Artoxan, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. Studies have shown that tenoxicam effectively reduces pain and inflammation in patients with various musculoskeletal disorders. Research published in the Journal of Clinical Rheumatology demonstrated the efficacy of tenoxicam in improving pain and function in patients with osteoarthritis.

Additional Information:

Artoxan has a longer half-life compared to other NSAIDs, allowing for once-daily dosing. It is well-tolerated in most patients, with gastrointestinal side effects being the most common. It is important to monitor for signs of gastrointestinal bleeding during treatment with Artoxan.

Artoxan (Tenoxicam) is a valuable option for the management of pain and inflammation associated with arthritis. Its pharmacological action involves inhibiting prostaglandin synthesis, thereby reducing inflammation and pain. Clinical trials have shown Artoxan to be as effective as other NSAIDs in providing symptomatic relief with the added benefit of once-daily dosing.

Research studies have highlighted the safety and efficacy of Artoxan in the treatment of various arthritic conditions. A study published in the Journal of International Medical Research demonstrated the superior gastrointestinal tolerability of tenoxicam compared to other NSAIDs, making it a preferred choice for patients at risk of gastrointestinal complications.